Completed PHASE4 INTERVENTIONAL NCT00273481

Cosopt Versus Xalacom

Sponsor: Pharmaceutical Research Network

Conditions Ocular Hypertension Open-Angle Glaucoma

Interventions dorzolamide 2%/timolol maleate 0.5% fixed combination latanoprost 0.005%/timolol maleate 0.5% fixed combination placebo timolol maleate 0.5%

Updated 6 times since 2017 Last updated: Nov 18, 2008 Started: Sep 30, 2005 Completion: Apr 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Ocular Hypertension and Open-Angle Glaucoma, this trial is completed. The trial is conducted by Pharmaceutical Research Network and has accumulated 6 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pharmaceutical Research Network

Data source: Pharmaceutical Research Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ljubljana, Slovenia
• London, Canada